News

EDGE endowment recipients Hyalose and Cytovance Biologics® partner to produce sugar-based therapeutics for evaluation, sale and licensing for an Oklahoma glycol-manufacturing facility.

http://newsok.com/edge-endowment-policy-board-gives-research-nod-in-oklahoma/article/3320972